25 XP   0   0   10

Annovis Bio Inc
Buy, Hold or Sell?

Let's analyse Annovis Bio Inc together

PenkeI guess you are interested in Annovis Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Annovis Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Annovis Bio Inc

I send you an email if I find something interesting about Annovis Bio Inc.

Quick analysis of Annovis Bio Inc (30 sec.)










What can you expect buying and holding a share of Annovis Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.70
Expected worth in 1 year
$-3.98
How sure are you?
12.5%

+ What do you gain per year?

Total Gains per Share
$-3.28
Return On Investment
-45.0%

For what price can you sell your share?

Current Price per Share
$7.28
Expected price per share
$12.58 - $8.86
How sure are you?
50%

1. Valuation of Annovis Bio Inc (5 min.)




Live pricePrice per Share (EOD)

$7.28

Intrinsic Value Per Share

$-50.83 - $-60.40

Total Value Per Share

$-51.53 - $-61.10

2. Growth of Annovis Bio Inc (5 min.)




Is Annovis Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$7.7m$33.8m-$23.9m-240.7%

How much money is Annovis Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$18.9m-$6.2m-$12.7m-67.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Annovis Bio Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#938 / 1007

Most Revenue
#877 / 1007

Most Profit
#682 / 1007

Most Efficient
#319 / 1007

What can you expect buying and holding a share of Annovis Bio Inc? (5 min.)

Welcome investor! Annovis Bio Inc's management wants to use your money to grow the business. In return you get a share of Annovis Bio Inc.

What can you expect buying and holding a share of Annovis Bio Inc?

First you should know what it really means to hold a share of Annovis Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Annovis Bio Inc is $7.28. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Annovis Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Annovis Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.70. Based on the TTM, the Book Value Change Per Share is $-0.82 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.37 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Annovis Bio Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.02-27.7%-1.28-17.5%-0.84-11.5%-0.52-7.1%-0.43-6.0%
Usd Book Value Change Per Share-1.31-18.0%-0.82-11.3%-0.37-5.0%0.000.0%-0.04-0.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.31-18.0%-0.82-11.3%-0.37-5.0%0.000.0%-0.04-0.5%
Usd Price Per Share18.70-14.47-12.96-14.61-12.18-
Price to Earnings Ratio-2.32--3.14--4.32--11.76--9.80-
Price-to-Total Gains Ratio-14.29-54.25--49.30--34.38--34.38-
Price to Book Ratio-26.57-1.29-4.32-7.45-6.21-
Price-to-Total Gains Ratio-14.29-54.25--49.30--34.38--34.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.28
Number of shares137
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.820.00
Usd Total Gains Per Share-0.820.00
Gains per Quarter (137 shares)-112.21-0.10
Gains per Year (137 shares)-448.83-0.39
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-449-4590-0-10
20-898-9080-1-10
30-1346-13570-1-10
40-1795-18060-2-10
50-2244-22550-2-10
60-2693-27040-2-10
70-3142-31530-3-10
80-3591-36020-3-10
90-4039-40510-4-10
100-4488-45000-4-10

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.024.00.00.0%0.028.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%3.017.00.015.0%3.018.03.012.5%4.021.03.014.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.024.00.0%0.00.028.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%3.017.00.015.0%3.018.03.012.5%4.021.03.014.3%

Fundamentals of Annovis Bio Inc

About Annovis Bio Inc

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.

Fundamental data was last updated by Penke on 2024-04-12 22:26:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Annovis Bio Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Annovis Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Annovis Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--216.8%+216.8%
YOY--282.4%+282.4%
5Y--434.0%+434.0%
10Y--584.8%+584.8%
1.1.2. Return on Assets

Shows how efficient Annovis Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • -217.6% Return on Assets means that Annovis Bio Inc generated $-2.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Annovis Bio Inc:

  • The MRQ is -217.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -129.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-217.6%TTM-129.7%-87.9%
TTM-129.7%YOY-17.2%-112.5%
TTM-129.7%5Y-48.4%-81.3%
5Y-48.4%10Y-55.2%+6.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-217.6%-13.2%-204.4%
TTM-129.7%-12.7%-117.0%
YOY-17.2%-11.5%-5.7%
5Y-48.4%-13.8%-34.6%
10Y-55.2%-15.5%-39.7%
1.1.3. Return on Equity

Shows how efficient Annovis Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Annovis Bio Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Annovis Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-103.3%+103.3%
TTM-103.3%YOY-18.6%-84.8%
TTM-103.3%5Y-32.4%-70.9%
5Y-32.4%10Y-28.3%-4.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.7%+16.7%
TTM-103.3%-15.9%-87.4%
YOY-18.6%-14.7%-3.9%
5Y-32.4%-19.2%-13.2%
10Y-28.3%-20.0%-8.3%

1.2. Operating Efficiency of Annovis Bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Annovis Bio Inc is operating .

  • Measures how much profit Annovis Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Annovis Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM--238.5%+238.5%
YOY--291.9%+291.9%
5Y--485.6%+485.6%
10Y--610.8%+610.8%
1.2.2. Operating Ratio

Measures how efficient Annovis Bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Annovis Bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.235-3.235
TTM-3.310-3.310
YOY-3.791-3.791
5Y-5.675-5.675
10Y-7.558-7.558

1.3. Liquidity of Annovis Bio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Annovis Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.39 means the company has $2.39 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Annovis Bio Inc:

  • The MRQ is 2.386. The company is able to pay all its short-term debts. +1
  • The TTM is 5.244. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.386TTM5.244-2.859
TTM5.244YOY20.027-14.783
TTM5.2445Y15.622-10.378
5Y15.62210Y13.022+2.600
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3863.877-1.491
TTM5.2444.178+1.066
YOY20.0275.343+14.684
5Y15.6226.135+9.487
10Y13.0226.468+6.554
1.3.2. Quick Ratio

Measures if Annovis Bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • A Quick Ratio of 1.34 means the company can pay off $1.34 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Annovis Bio Inc:

  • The MRQ is 1.345. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 3.452. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.345TTM3.452-2.107
TTM3.452YOY19.498-16.046
TTM3.4525Y15.038-11.586
5Y15.03810Y12.534+2.504
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3453.514-2.169
TTM3.4523.998-0.546
YOY19.4985.380+14.118
5Y15.0386.135+8.903
10Y12.5346.434+6.100

1.4. Solvency of Annovis Bio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Annovis Bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Annovis Bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.76 means that Annovis Bio Inc assets are financed with 175.9% credit (debt) and the remaining percentage (100% - 175.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Annovis Bio Inc:

  • The MRQ is 1.759. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 0.603. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ1.759TTM0.603+1.157
TTM0.603YOY0.089+0.514
TTM0.6035Y4.106-3.504
5Y4.10610Y9.683-5.576
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7590.339+1.420
TTM0.6030.336+0.267
YOY0.0890.271-0.182
5Y4.1060.368+3.738
10Y9.6830.388+9.295
1.4.2. Debt to Equity Ratio

Measures if Annovis Bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Annovis Bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.226-0.226
TTM0.226YOY0.106+0.120
TTM0.2265Y0.101+0.125
5Y0.10110Y0.100+0.001
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.388-0.388
TTM0.2260.403-0.177
YOY0.1060.340-0.234
5Y0.1010.430-0.329
10Y0.1000.463-0.363

2. Market Valuation of Annovis Bio Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Annovis Bio Inc generates.

  • Above 15 is considered overpriced but always compare Annovis Bio Inc to the Biotechnology industry mean.
  • A PE ratio of -2.32 means the investor is paying $-2.32 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Annovis Bio Inc:

  • The EOD is -0.902. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.317. Based on the earnings, the company is expensive. -2
  • The TTM is -3.143. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.902MRQ-2.317+1.415
MRQ-2.317TTM-3.143+0.826
TTM-3.143YOY-4.319+1.176
TTM-3.1435Y-11.763+8.620
5Y-11.76310Y-9.802-1.960
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.902-2.281+1.379
MRQ-2.317-2.599+0.282
TTM-3.143-2.674-0.469
YOY-4.319-4.133-0.186
5Y-11.763-6.258-5.505
10Y-9.802-6.270-3.532
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Annovis Bio Inc:

  • The EOD is -2.140. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.497. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.326. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.140MRQ-5.497+3.357
MRQ-5.497TTM-4.326-1.171
TTM-4.326YOY-9.132+4.806
TTM-4.3265Y-14.818+10.492
5Y-14.81810Y-12.348-2.470
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.140-2.903+0.763
MRQ-5.497-3.323-2.174
TTM-4.326-3.552-0.774
YOY-9.132-5.592-3.540
5Y-14.818-8.378-6.440
10Y-12.348-8.875-3.473
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Annovis Bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -26.57 means the investor is paying $-26.57 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Annovis Bio Inc:

  • The EOD is -10.342. Based on the equity, the company is expensive. -2
  • The MRQ is -26.566. Based on the equity, the company is expensive. -2
  • The TTM is 1.285. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-10.342MRQ-26.566+16.224
MRQ-26.566TTM1.285-27.852
TTM1.285YOY4.324-3.039
TTM1.2855Y7.448-6.163
5Y7.44810Y6.207+1.241
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.3421.911-12.253
MRQ-26.5662.116-28.682
TTM1.2852.097-0.812
YOY4.3242.885+1.439
5Y7.4483.556+3.892
10Y6.2073.959+2.248
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Annovis Bio Inc.

3.1. Institutions holding Annovis Bio Inc

Institutions are holding 11.501% of the shares of Annovis Bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc3.18860.00013373547882430.4893
2023-12-31Adage Capital Partners Gp LLC2.69710.0111285347-14653-4.8843
2023-12-31BlackRock Inc0.90720.000195984-297-0.3085
2023-12-31Geode Capital Management, LLC0.65010.0001687761273622.7266
2023-12-31Wescott Financial Advisory Group, LLC0.39330.1094160700
2023-12-31Sterling Investment Advisors Ltd0.32490.20023437400
2023-12-31Redmond Asset Management, LLC0.32210.20543408000
2023-12-31Marshall Wace Asset Management Ltd0.3080.00132582325820
2023-12-31Modera Wealth Management, LLC0.28840.00943051300
2023-12-31Northern Trust Corp0.27460.00012904818868185.3438
2023-12-31Bridgeway Capital Management, LLC0.22310.00952360000
2023-12-31State Street Corporation0.2224023535430022.3551
2023-12-31Merit Financial Group, LLC0.20980.012622200-19000-46.1165
2023-12-31Bank of New York Mellon Corp0.19570.000120705-13067-38.6918
2023-12-31Susquehanna International Group, LLP0.14910.000115772157720
2023-12-31TWO SIGMA SECURITIES, LLC0.11610.002212282122820
2023-12-31Citigroup Inc0.10580.000211197111970
2023-12-31Dimensional Fund Advisors, Inc.0.10490.000111095-11491-50.8766
2023-12-31Sontag Advisory LLC0.10390.0029109909909.9
2023-12-31LPL Financial Corp0.10010.000110588105880
Total 10.88520.56431151629+139631+12.1%

3.2. Funds holding Annovis Bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.0480.000122550700
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.91990.000810129800
2024-02-29Fidelity Extended Market Index0.36060.000939711-192-0.4812
2023-12-31Bridgeway Ultra-Small Company Market0.20430.22642250000
2024-03-28iShares Micro-Cap ETF0.14410.02051586300
2023-09-30BlackRock Extended Mkt Composite0.12140.00091337100
2024-02-29Fidelity Total Market Index0.11890.00011309100
2024-03-31BlackRock Extended Equity Market K0.1060.0011166940.0343
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.09460.0031104226008136.1124
2024-02-29Fidelity Series Total Market Index0.09120.000110046-335-3.227
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0760.003183704832136.5743
2023-12-31NT Ext Equity Mkt Idx Fd - L0.06340.00226980171432.5484
2023-12-31Northern Trust Extended Eq Market Idx0.06340.00226980171432.5484
2023-12-31T. Rowe Price Extended Equity Market Idx0.04360.0094480000
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.0410.0001451800
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.0410.00014518-156489-97.1939
2024-02-29Spartan Total Market Index Pool E0.03960.0001435600
2024-02-29Vanguard Balanced Index Inv0.03720.0001410000
2024-02-29Spartan Extended Market Index Pool E0.03220.001235411925.7331
2024-03-31BlackRock U.S. Equity Market F0.0190.00022093200.9648
Total 4.66540.2726513734-142532-27.7%

3.3. Insider Transactions

Insiders are holding 24.593% of the shares of Annovis Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-10-11Claudine BruckBUY18127.66
2021-10-11Maria-luisa MaccecchiniBUY1800027.61
2021-08-19Reid MccarthyBUY50037.61

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Annovis Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.309-0.819-37%-0.367-72%-0.001-100%-0.036-97%
Book Value Per Share---0.7040.903-178%3.078-123%1.468-148%1.214-158%
Current Ratio--2.3865.244-55%20.027-88%15.622-85%13.022-82%
Debt To Asset Ratio--1.7590.603+192%0.089+1876%4.106-57%9.683-82%
Debt To Equity Ratio---0.226-100%0.106-100%0.101-100%0.100-100%
Dividend Per Share----0%-0%-0%-0%
Eps---2.017-1.276-37%-0.839-58%-0.518-74%-0.434-78%
Free Cash Flow Per Share---0.850-0.841-1%-0.393-54%-0.308-64%-0.259-70%
Free Cash Flow To Equity Per Share---0.055-0.447+720%-0.288+429%266.788-100%222.324-100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---60.395--------
Intrinsic Value_10Y_min---50.825--------
Intrinsic Value_1Y_max---2.523--------
Intrinsic Value_1Y_min---2.476--------
Intrinsic Value_3Y_max---10.270--------
Intrinsic Value_3Y_min---9.750--------
Intrinsic Value_5Y_max---21.260--------
Intrinsic Value_5Y_min---19.501--------
Market Cap80162264.000-157%205911310.000159361039.250+29%142651391.500+44%160886104.300+28%134071753.583+54%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio-10.342+61%-26.5661.285-2167%4.324-714%7.448-457%6.207-528%
Pe Ratio-0.902+61%-2.317-3.143+36%-4.319+86%-11.763+408%-9.802+323%
Price Per Share7.280-157%18.70014.473+29%12.955+44%14.611+28%12.176+54%
Price To Free Cash Flow Ratio-2.140+61%-5.497-4.326-21%-9.132+66%-14.818+170%-12.348+125%
Price To Total Gains Ratio-5.563+61%-14.29054.245-126%-49.300+245%-34.381+141%-34.381+141%
Quick Ratio--1.3453.452-61%19.498-93%15.038-91%12.534-89%
Return On Assets---2.176-1.297-40%-0.172-92%-0.484-78%-0.552-75%
Return On Equity----1.0330%-0.1860%-0.3240%-0.2830%
Total Gains Per Share---1.309-0.819-37%-0.367-72%-0.001-100%-0.036-97%
Usd Book Value---7750846.0009946518.000-178%33887569.750-123%16167297.200-148%13370085.167-158%
Usd Book Value Change Per Share---1.309-0.819-37%-0.367-72%-0.001-100%-0.036-97%
Usd Book Value Per Share---0.7040.903-178%3.078-123%1.468-148%1.214-158%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---2.017-1.276-37%-0.839-58%-0.518-74%-0.434-78%
Usd Free Cash Flow---9364976.000-9257392.000-1%-4328233.500-54%-3396101.300-64%-2853359.792-70%
Usd Free Cash Flow Per Share---0.850-0.841-1%-0.393-54%-0.308-64%-0.259-70%
Usd Free Cash Flow To Equity Per Share---0.055-0.447+720%-0.288+429%266.788-100%222.324-100%
Usd Market Cap80162264.000-157%205911310.000159361039.250+29%142651391.500+44%160886104.300+28%134071753.583+54%
Usd Price Per Share7.280-157%18.70014.473+29%12.955+44%14.611+28%12.176+54%
Usd Profit---22213394.000-18977802.500-15%-6259324.000-72%-6094433.250-73%-5108439.000-77%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---1.309-0.819-37%-0.367-72%-0.001-100%-0.036-97%
 EOD+2 -6MRQTTM+8 -20YOY+8 -205Y+7 -2110Y+7 -21

4.2. Fundamental Score

Let's check the fundamental score of Annovis Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.902
Price to Book Ratio (EOD)Between0-1-10.342
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.345
Current Ratio (MRQ)Greater than12.386
Debt to Asset Ratio (MRQ)Less than11.759
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.176
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Annovis Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.050
Ma 20Greater thanMa 5011.411
Ma 50Greater thanMa 10010.538
Ma 100Greater thanMa 20011.300
OpenGreater thanClose18.000
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Stockholder Equity 28,324-8,18720,13660720,743-14,0846,658-14,409-7,751
Net Invested Capital  28,324-8,18720,13660720,743-14,0846,658-14,409-7,751



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets10,208
Total Liabilities17,959
Total Stockholder Equity-7,751
 As reported
Total Liabilities 17,959
Total Stockholder Equity+ -7,751
Total Assets = 10,208

Assets

Total Assets10,208
Total Current Assets10,208
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 5,755
Other Current Assets 4,454
Total Current Assets  (as reported)10,208
Total Current Assets  (calculated)10,208
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,279
Long-term Liabilities13,680
Total Stockholder Equity-7,751
Total Current Liabilities
Accounts payable 1,293
Other Current Liabilities 2,986
Total Current Liabilities  (as reported)4,279
Total Current Liabilities  (calculated)4,279
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)13,680
Long-term Liabilities  (calculated)0
+/- 13,680
Total Stockholder Equity
Common Stock1
Retained Earnings -110,259
Other Stockholders Equity 102,507
Total Stockholder Equity (as reported)-7,751
Total Stockholder Equity (calculated)-7,751
+/-0
Other
Capital Stock1
Cash and Short Term Investments 5,755
Common Stock Shares Outstanding 9,525
Liabilities and Stockholders Equity 10,208
Net Debt -5,755
Net Invested Capital -7,751
Net Working Capital 5,929



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
2,835
2,613
2,185
1,926
0
0
0
51
431
300
380
1,117
11,441
10,201
9,402
8,119
5,965
49,496
47,650
46,001
43,297
36,525
32,487
36,022
25,547
22,816
10,223
10,208
10,20810,22322,81625,54736,02232,48736,52543,29746,00147,65049,4965,9658,1199,40210,20111,4411,117380300431510001,9262,1852,6132,835
   > Total Current Assets 
1,593
1,478
1,145
986
0
0
0
51
400
149
99
748
11,441
10,201
9,402
8,119
5,965
49,496
47,650
46,001
43,297
36,525
32,487
36,022
25,547
22,816
10,223
10,208
10,20810,22322,81625,54736,02232,48736,52543,29746,00147,65049,4965,9658,1199,40210,20111,44174899149400510009861,1451,4781,593
       Cash And Cash Equivalents 
72
164
121
28
0
0
0
35
337
105
56
2
11,120
9,763
8,841
8,075
5,603
49,224
47,455
45,686
42,669
35,974
31,987
28,378
16,759
15,725
6,355
5,755
5,7556,35515,72516,75928,37831,98735,97442,66945,68647,45549,2245,6038,0758,8419,76311,120256105337350002812116472
       Net Receivables 
1,474
1,255
981
919
0
0
0
0
0
0
0
735
38
199
425
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000004251993873500000009199811,2551,474
       Inventory 
23
22
21
20
0
0
0
0
0
0
0
0
278
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000002780000000020212223
       Other Current Assets 
24
38
23
19
0
0
0
16
64
45
42
11
5
239
136
45
362
272
195
315
628
551
500
7,644,376
8,788,597
26
3,868
4,454
4,4543,868268,788,5977,644,376500551628315195272362451362395114245641600019233824
   > Long-term Assets 
0
0
0
0
0
0
0
0
31
151
281
370
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000003702811513100000000
       Property Plant Equipment 
65
63
64
64
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000064646365
       Intangible Assets 
1,177
1,071
976
876
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000008769761,0711,177
       Other Assets 
0
0
0
0
0
0
0
0
31
151
281
370
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000003702811513100000000
> Total Liabilities 
174
105
102
216
0
0
0
7,645
8,207
8,421
8,755
9,694
749
703
281
578
1,597
884
1,121
1,507
1,256
1,299
2,527
7,699
5,411
2,074
3,565
17,959
17,9593,5652,0745,4117,6992,5271,2991,2561,5071,1218841,5975782817037499,6948,7558,4218,2077,645000216102105174
   > Total Current Liabilities 
174
105
102
216
0
0
0
568
608
794
1,126
2,011
749
703
281
578
1,597
884
1,121
1,507
1,256
1,299
2,527
7,699
5,411
2,074
3,565
4,279
4,2793,5652,0745,4117,6992,5271,2991,2561,5071,1218841,5975782817037492,0111,126794608568000216102105174
       Accounts payable 
174
105
102
216
0
0
0
68
10
0
425
1,234
55
124
140
342
825
115
290
688
929
902
1,846
3,961
4,153
1,173
1,926
1,293
1,2931,9261,1734,1533,9611,846902929688290115825342140124551,23442501068000216102105174
       Other Current Liabilities 
0
0
0
0
0
0
0
500
598
794
701
777
695
578
141
237
772
769
831
818
327
398
681
3,737
1,258
901
1,638
2,986
2,9861,6389011,2583,7376813983278188317697722371415786957777017945985000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
7,077
7,599
7,627
7,628
7,683
0
0
0
0
0
0
0
688
929
902
1,846
3,961
4,152,940
0
0
13,680
13,680004,152,9403,9611,84690292968800000007,6837,6287,6277,5997,0770000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
496
497
498
500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000050049849749600000000
       Other Liabilities 
0
0
0
0
0
0
0
0
27
53
53
106
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000010653532700000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
31
151
281
370
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000003702811513100000000
> Total Stockholder Equity
2,661
2,507
2,083
1,710
0
0
0
-7,594
-7,776
-8,121
-8,375
-8,576
10,692
9,498
9,121
7,541
4,368
48,612
46,530
44,495
42,040
35,226
29,961
28,324
20,136
20,743
6,658
-7,751
-7,7516,65820,74320,13628,32429,96135,22642,04044,49546,53048,6124,3687,5419,1219,49810,692-8,576-8,375-8,121-7,776-7,5940001,7102,0832,5072,661
   Common Stock
57
57
57
57
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
11111111111111110000000057575757
   Retained Earnings Total Equity00-73,329-63,7920-50,960-43,3390-28,726-22,812-19,963-17,439-14,239000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
201
201
201
201
19,910
0
0
21,779
21,806
68,575
69,341
73,220
0
78,564
80,920
0
83,927
94,071
0
0
0094,07183,927080,92078,564073,22069,34168,57521,80621,7790019,91020120120120100000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
1,267
1,262
1,240
1,250
0
0
0
192
201
201
201
201
19,910
21,026
21,655
21,779
21,806
68,575
69,341
73,220
76,660
78,564
80,920
82,377
83,927
94,071
94,703
102,507
102,50794,70394,07183,92782,37780,92078,56476,66073,22069,34168,57521,80621,77921,65521,02619,9102012012012011920001,2501,2401,2621,267



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-45,035
Operating Income-45,035-45,035
 
Operating Expense (+$)
Research Development38,791
Selling General Administrative6,244,408
Selling And Marketing Expenses6,238,164
Operating Expense45,03512,521,362
 
Net Interest Income (+$)
Interest Income676
Interest Expense-0
Other Finance Cost-0
Net Interest Income676
 
Pretax Income (+$)
Operating Income-45,035
Net Interest Income676
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-56,204-33,866
EBIT - interestExpense = 0
-56,204
-56,204
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-56,204
Earnings Before Interest and Taxes (EBITDA)-45,035
 
After tax Income (+$)
Income Before Tax-56,204
Tax Provision-0
Net Income From Continuing Ops-41,717-56,204
Net Income-56,204
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses45,035
Total Other Income/Expenses Net-11,169-676
 

Technical Analysis of Annovis Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Annovis Bio Inc. The general trend of Annovis Bio Inc is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Annovis Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Annovis Bio Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 8.1001 < 8.76 < 8.86.

The bearish price targets are: 13.50 > 13.26 > 12.58.

Tweet this
Annovis Bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Annovis Bio Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Annovis Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Annovis Bio Inc. The current macd is 0.39243172.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Annovis Bio Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Annovis Bio Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Annovis Bio Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Annovis Bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartAnnovis Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Annovis Bio Inc. The current adx is 27.19.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Annovis Bio Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Annovis Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Annovis Bio Inc. The current sar is 20.00.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Annovis Bio Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Annovis Bio Inc. The current rsi is 40.05. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Annovis Bio Inc Daily Relative Strength Index (RSI) ChartAnnovis Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Annovis Bio Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Annovis Bio Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Annovis Bio Inc Daily Stochastic Oscillator ChartAnnovis Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Annovis Bio Inc. The current cci is -48.95012441.

Annovis Bio Inc Daily Commodity Channel Index (CCI) ChartAnnovis Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Annovis Bio Inc. The current cmo is -25.14398479.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Annovis Bio Inc Daily Chande Momentum Oscillator (CMO) ChartAnnovis Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Annovis Bio Inc. The current willr is -86.12051456.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Annovis Bio Inc Daily Williams %R ChartAnnovis Bio Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Annovis Bio Inc.

Annovis Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Annovis Bio Inc. The current atr is 2.26868404.

Annovis Bio Inc Daily Average True Range (ATR) ChartAnnovis Bio Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Annovis Bio Inc. The current obv is -3,297,076.

Annovis Bio Inc Daily On-Balance Volume (OBV) ChartAnnovis Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Annovis Bio Inc. The current mfi is 26.62.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Annovis Bio Inc Daily Money Flow Index (MFI) ChartAnnovis Bio Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Annovis Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Annovis Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Annovis Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.050
Ma 20Greater thanMa 5011.411
Ma 50Greater thanMa 10010.538
Ma 100Greater thanMa 20011.300
OpenGreater thanClose18.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Annovis Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Annovis Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Annovis Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Annovis Bio Inc

I send you an email if I find something interesting about Annovis Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Annovis Bio Inc.

Receive notifications about Annovis Bio Inc in your mailbox!